NAALADL2 _LIHC.png
Expression analysis of TCGA samples
Basic Information
VIS ID
TVIS10019865
Fusion event
HBV-NAALADL2 integration
Validated
No
Detection method
VirusFinder
Data source
Curated
Sample type
Nontumor
Disease
Hepatocellular carcinoma (HCC)
Quality evaluation
Normal
Reported year
2017
PubMed ID
29212479
Virus Sequence
Virus name
HBV
Reference genome
NC_003977
Start
1806
Integrated sequence
ACTTCAAAGACTGTTTGTTTAAAGACTGGGAGGAGTTGGGGGAGGAGATTAGGTTAAAGGTCTTTGTACTAGGAGGCTGTAGGCATAAATTGGTCTGCGC| |ACCAGCACCATGCAACTTTTTCACCTCTGCCTAATCATCTCTTGTTCATGTCCTACTGTTCAAGCCTCCAAGCTGTGCCTTGGGTGGCTTTGGGGCATGG
Host Sequence
Chromosome
chr3
Cytoband
q26.31
Reference genome
GRCh37.55
Start
174421698/174703908 (Hg38)
End
174421698/174703908 (Hg38)
Location type
Intronic
Target gene
NAALADL2
Nearest miRNA
hsa-let-7g/Upstream/3597149; hsa-mir-1224/Downstream/665632;
Nearest TSS
ENST00000440867/Upstream/262921; ENST00000485853/Downstream/155372;
Nearest CpG islands
None/Target, chr3-CpG: 148/Upstream/262350, chr3-CpG: 133/Downstream/2492541
Nearby gene
NAALADL2
Upstream sequence
tatgtgtgtgtgtgcatgcatgcatgtgcgcacgtgGACGTGAAGGAGTCTGAAGAGTTTCCGGAAACGGCTAGTTTTCTAGCTGCAATCTTCAGTTTGG
Downstream sequence
GAAAATTTTTTCAGTCTGTGCATGCTCTAGGCTGGACTGAATGCTAAGTGCTTTACCTTACAAACTTGCTGGAGAAAAGGAGAATCTACTTTATCTATCA
Reference
Yoo, S., et al. A pilot systematic genomic comparison of recurrence risks of hepatitis B virus-associated hepatocellular carcinoma with low- and high-degree liver fibrosis. BMC Med ,2017, 15(1): 214.
Curate